Verified July 2026 · Cited to primary sources
Thymosin Alpha-1: Evidence Grade B. Real human trials, limited or historical.
The honest verdict
The strongest immune peptide in this group on human evidence. It is a genuine approved drug in dozens of countries with real randomized-trial support in sepsis and hepatitis, which is why it grades a B. But it never cleared the FDA, so in the US it is research-only, and the sepsis mortality signal, while promising, has not been confirmed in a definitive Western trial. If you want an immune peptide with actual clinical pedigree, this is it, but treat US-sourced material with skepticism and do not use it to self-treat serious illness.
Thymosin Alpha-1 at a glance
- Class
- Immunomodulatory peptide (thymic peptide)
- Mechanism
- Synthetic copy of a peptide the thymus makes naturally. It signals through Toll-like receptors (mainly TLR9 and TLR2) on dendritic cells and immune cells, which pushes maturation of T cells, boosts natural killer cell activity, and shifts the immune response toward a Th1 (antiviral, antitumor) pattern. It is an immune tuner rather than a straight stimulant, so it gets studied in both underactive immunity (infection, sepsis) and settings where you want a stronger antiviral or antitumor response.
- Also known as
- Ta1, Thymalfasin, Zadaxin, Thymosin alpha 1, TA-1
- Research applications
- Chronic hepatitis B and C (approved abroad, now largely displaced by direct antivirals)
- Severe sepsis as add-on immunomodulation
- Cancer immunotherapy adjunct
- Vaccine response enhancement in older or immunocompromised people
- Respiratory infection
- Forms
- Subcutaneous injection (lyophilized powder for reconstitution)
- Legal status
- Research-only
- WADA (anti-doping)
- Not on the WADA Prohibited List as a named substance, but immunomodulatory peptides sit in a gray area. Not an established performance-enhancer.
- Evidence grade
- Grade BReal human trials, limited or historical
How we grade evidence
Every grade comes from a fixed A to F rubric: human-trial strength, not hype or affiliate status. Last verified July 6, 2026.
What is Thymosin Alpha-1?
A 28-amino-acid thymic peptide that tunes the immune system. Approved as a drug (Zadaxin) in ~35 countries for hepatitis and immune support, but never FDA-approved, so in the US it is research-only.
Synthetic copy of a peptide the thymus makes naturally. It signals through Toll-like receptors (mainly TLR9 and TLR2) on dendritic cells and immune cells, which pushes maturation of T cells, boosts natural killer cell activity, and shifts the immune response toward a Th1 (antiviral, antitumor) pattern. It is an immune tuner rather than a straight stimulant, so it gets studied in both underactive immunity (infection, sepsis) and settings where you want a stronger antiviral or antitumor response.
How strong is the evidence for Thymosin Alpha-1?
Approved as a prescription drug in roughly 35 countries (hepatitis B/C, immune support) and backed by multiple randomized human trials. The ETASS multicenter RCT (n=361) in severe sepsis showed a 9% absolute drop in 28-day mortality (26.0% vs 35.0%), though it just missed statistical significance (p=0.062). A systematic review of RCTs found a significant mortality benefit in sepsis (RR 0.59). The catch: trials are mostly China-based, quality is graded low-to-moderate, and it is NOT FDA-approved. So the human evidence is real and multi-trial (well above animal-only), but not a clean US-approved A.
Primary sources (3)
Is Thymosin Alpha-1 legal? (Status July 2026)
No legal supervised US route.
What is Thymosin Alpha-1 used for?
Thymosin Alpha-1 is marketed for the goals below. See how it ranks against other peptides in each, by evidence, not hype.
What does Thymosin Alpha-1 cost, and how do you access it legally?
Typical cost
$40 to $90 per vial (research-grade, typically 5mg to 10mg)
Research-grade vials from peptide suppliers vary widely by purity and quantity. The FDA-approved Zadaxin drug abroad costs far more and is not sold to US consumers. Cheap research vials carry no guarantee of identity or sterility.
No legal supervised access route right now.
Thymosin Alpha-1 has no compliant US route today. Vials sold "for research use only" are a gray-market fig-leaf, not a legal loophole, so we don't link them. If you pursue Thymosin Alpha-1, do it with a licensed clinician, and re-check its legal status first.
Is Thymosin Alpha-1safe? Side effects & risks
Long real-world safety record abroad as Zadaxin, and trials report it is generally well tolerated with few serious adverse events. But it is not FDA-approved in the US, so any US access is through research-only or unregulated channels with no manufacturing oversight. As an immune modulator it is a theoretical concern for anyone with autoimmune disease or on immunosuppressants. Human safety data outside the approved hepatitis and sepsis settings (for example, general wellness or longevity dosing) is thin. Not for self-experimentation without medical supervision.
Medical disclaimer: This page is independent editorial information, not medical advice, and Best Peptide For That is not a medical provider. We do not provide dosing. Talk to a licensed clinician before starting, stopping, or changing any peptide or medication. Full medical disclaimer.
FAQ
Thymosin Alpha-1 FAQ
Is thymosin alpha-1 FDA-approved?
No. Despite being approved as the drug Zadaxin (thymalfasin) in around 35 countries, it was never approved by the FDA, reportedly because the company judged US registration trials too costly. In the US it is research-only.
Does it actually work for anything?
The best human evidence is in severe sepsis, where randomized trials and a systematic review point to a mortality benefit, and in chronic hepatitis B/C, where it was approved abroad before direct antivirals largely replaced it. Wellness and longevity claims are not backed by trials.
Is it safe?
It has a good tolerability record in trials and decades of use abroad, but US-sourced research material has no quality oversight, and immune modulators can be risky for people with autoimmune conditions or on immunosuppressive drugs.
From our portfolio
Tracking Thymosin Alpha-1?
Titrate is an iOS app for logging doses, schedules and progress over time, with a reconstitution calculator built in. It tracks, it does not prescribe.
Keep reading
KPV
An anti-inflammatory tripeptide studied for gut and skin inflammation. Promising in cells and animals, untested in humans.
Grade CLL-37 (Cathelicidin)
The body's own 37-amino-acid antimicrobial peptide. It has genuine human wound-healing trials, but the largest one (phase 2b) failed its main endpoint, so the evidence is a mixed, small-scale C.
Grade CVIP (Vasoactive Intestinal Peptide / Aviptadil)
A natural 28-amino-acid neuropeptide with broad signaling roles. Its big FDA push (aviptadil for COVID) failed a phase 3 trial and the FDA declined authorization, so the evidence is a mixed C.
The monthly peptide evidence brief.
What the research and the FDA actually say, in one short email a month. Unsubscribe anytime.
No spam. We never sell your email. Editorial policy.